GLORY HEALTH IND. HD-001 (84R) - Net Assets
Based on the latest financial reports, GLORY HEALTH IND. HD-001 (84R) has net assets worth €10.60 Billion EUR (≈ $12.39 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€54.19 Billion ≈ $63.35 Billion USD) and total liabilities (€43.59 Billion ≈ $50.96 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GLORY HEALTH IND. HD-001 tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.60 Billion |
| % of Total Assets | 19.56% |
| Annual Growth Rate | -8.97% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.81 |
GLORY HEALTH IND. HD-001 - Net Assets Trend (2021–2025)
This chart illustrates how GLORY HEALTH IND. HD-001's net assets have evolved over time, based on quarterly financial data. See GLORY HEALTH IND. HD-001 liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for GLORY HEALTH IND. HD-001 (2021–2025)
The table below shows the annual net assets of GLORY HEALTH IND. HD-001 from 2021 to 2025. For live valuation and market cap data, see 84R market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €10.60 Billion ≈ $12.39 Billion |
-14.30% |
| 2024-12-31 | €12.37 Billion ≈ $14.46 Billion |
-10.27% |
| 2023-12-31 | €13.79 Billion ≈ $16.12 Billion |
-4.13% |
| 2022-12-31 | €14.38 Billion ≈ $16.81 Billion |
-6.84% |
| 2021-12-31 | €15.43 Billion ≈ $18.05 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GLORY HEALTH IND. HD-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 626090400000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €6.26 Billion | 77.24% |
| Other Components | €1.85 Billion | 22.76% |
| Total Equity | €8.11 Billion | 100.00% |
GLORY HEALTH IND. HD-001 Competitors by Market Cap
The table below lists competitors of GLORY HEALTH IND. HD-001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Steel Hawk Berhad
KLSE:0320
|
$23.40 Million |
|
AJ Advance Technology Public Company Limited
BK:AJA
|
$23.41 Million |
|
BBC Co. Ltd.
KQ:318410
|
$23.45 Million |
|
Sareum Hldgs Plc
LSE:SAR
|
$23.47 Million |
|
PSQ Holdings Inc.
NYSE:PSQH
|
$23.38 Million |
|
Robit Oyj
HE:ROBIT
|
$23.38 Million |
|
Nova Leap Health Corp
V:NLH
|
$23.37 Million |
|
Inuvo Inc
NYSE MKT:INUV
|
$23.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GLORY HEALTH IND. HD-001's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,928,691,000 to 8,106,219,000, a change of -1,822,472,000 (-18.4%).
- Net loss of 1,822,472,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.82 Billion | -22.48% |
| Total Change | €- | -18.36% |
Book Value vs Market Value Analysis
This analysis compares GLORY HEALTH IND. HD-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €2.86 | €0.00 | x |
| 2022-12-31 | €2.64 | €0.00 | x |
| 2023-12-31 | €2.51 | €0.00 | x |
| 2024-12-31 | €2.23 | €0.00 | x |
| 2025-12-31 | €1.82 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GLORY HEALTH IND. HD-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -175.98%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 6.68x
- Recent ROE (-22.48%) is below the historical average (-9.20%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 1.80% | 2.31% | 0.16x | 4.81x | €-1.04 Billion |
| 2022 | -7.78% | -23.38% | 0.07x | 4.89x | €-2.09 Billion |
| 2023 | -5.05% | -22.50% | 0.04x | 5.05x | €-1.68 Billion |
| 2024 | -12.49% | -45.85% | 0.05x | 5.76x | €-2.23 Billion |
| 2025 | -22.48% | -175.98% | 0.02x | 6.68x | €-2.63 Billion |
Industry Comparison
This section compares GLORY HEALTH IND. HD-001's net assets metrics with peer companies in the Real Estate - Development industry.
Industry Context
- Industry: Real Estate - Development
- Average net assets among peers: $35,040,166,076
- Average return on equity (ROE) among peers: -54.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GLORY HEALTH IND. HD-001 (84R) | €10.60 Billion | 1.80% | 4.11x | $23.38 Million |
| REDSUN PROPERTIES GROUP (0RJ) | $23.80 Billion | -16.31% | 3.27x | $3.34 Million |
| CHINA VANKE CO.LTD H YC 1 (18V) | $235.86 Billion | -37.55% | 3.33x | $681.03 Million |
| ABITARE IN S.P.A. (1BN) | $96.01 Million | 8.22% | 3.00x | $65.18 Million |
| RONSHINE CH.HLD.HD-00001 (1R7) | $6.87 Billion | -174.60% | 13.49x | $15.74 Million |
| Pruksa Holding Public Company Limited (2PR3) | $38.66 Billion | 14.11% | 0.87x | $181.69 Million |
| Zhong An Group Limited (35Z) | $10.52 Billion | 6.06% | 1.87x | $32.78 Million |
| Sino-Ocean Group Holding Limited (3SD) | $1.90 Billion | 355.79% | 78.50x | $111.59 Million |
| BARKBY GRP PLC LS 000860 (3WY) | $823.00K | -512.03% | 26.44x | $125.67 Million |
| HUIJING HLDG.CO.LTD HD-01 (3XU) | $1.32 Billion | -186.00% | 8.26x | $7.88 Million |
| ZHONGLIANG HLDG HD-01 (3ZH) | $31.37 Billion | -4.29% | 6.58x | $10.40 Million |
About GLORY HEALTH IND. HD-001
Glory Health Industry Limited, an investment holding company, engages in the property development business in the People's Republic of China. The company operates through Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services segments. The Property Development segment develops and sells commercial and residential… Read more